Your browser doesn't support javascript.
loading
Gordon McVie: his legacy as a blueprint for cancer advocates as we strive towards the 2030 global health and sustainable development goals.
Pravettoni, Gabriella; Masiero, Marianna; Mugo-Sitati, Christine; Torode, Julie.
Afiliación
  • Pravettoni G; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.
  • Masiero M; Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology, IRCCS, Milan 20141, Italy.
  • Mugo-Sitati C; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.
  • Torode J; Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology, IRCCS, Milan 20141, Italy.
Ecancermedicalscience ; 16: 1341, 2022.
Article en En | MEDLINE | ID: mdl-35242222
ABSTRACT
Cancer prevention and control services worldwide must actively rebuild and contribute to improved health systems resilience alongside and beyond the COVID-19 (SARS-CoV-2 coronavirus disease) pandemic, especially in low- and middle-income countries. Cancer advocacy groups should respond to this unprecedented challenge as an opportunity to bolster community and patient involvement in research and clinical practice that is adjusted to local needs and circumstances. This short communication provides a synthesis of these critical challenges and, stemming from the pioneering activities of Gordon McVie on patient empowerment, urges policy makers and researchers to develop new implementation strategies that start from the social, economic and health consequences of the COVID-19 pandemic to overcome roadblocks in the access to cancer care. We propose that developing the domain of collaborative implementation research in national cancer control plans will be the key to consolidate patient-centred services with both an equity lens and a focus on integration of new technologies as all countries drive towards the 2030 goals of universal health coverage.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ecancermedicalscience Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ecancermedicalscience Año: 2022 Tipo del documento: Article País de afiliación: Italia